Abstract
The progressive accumulation of copper in hepatocytes of humans and animals may lead to hepatocellular necrosis (1–3). In Wilson’s disease, an inherited disorder of copper metabolism in humans, the excretion of copper into bile is impaired. The phenotype of the disease is caused by a mutation of the ATP7B gene leading to a nonfunctioning gene product, a copper-transporting P-type ATPase (4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sternlieb, I. (1980) Copper and the liver. Gastroenterology 78, 1615–1628.
Schilsky, M. L. and Sternlieb, I. (1993) Animal models of copper toxicosis. Anim. Mod. Liver Res. 37, 357–377.
Pandit, A. N. and Bhave, S. A. (1983) Copper and Indian childhood cirrhosis. Indian Pediatr. 20, 893–899.
Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., and Cox, D. W. (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet. 5, 327–337.
Yoshida, M. C., Masuda, R., Sasaki, M., Takeichi, N., Kobayashi, H., Dempo, K., et al. (1987) New mutation causing hereditary hepatitis in the laboratory rat. J. Hered. 78, 361–365.
Li, Y., Togashi, Y., Sato, S., Emoto, T., Kang, J. H., Takeichi, N., et al. (1991) Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. J. Clin. Invest. 87, 1858–1861.
Wu, J., Forbes, J. R., Chen, H. S., and Cox, D. W. (1994) The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nature Genet. 7, 541–545.
Sasaki, M., Yoshida, M. C., Kagami, K., Takeichi, N., Kobayashi, H., Dempo, K., et al. (1985) Spontaneous hepatitis in an inbred strain of Long-Evans rats. Rat News Lett. 14, 4–6.
Takeichi, N., Kobayashi, H., Yoshida, M. C., Sasaki, M., Dempo, K., and Mori, M. (1988) Spontaneous hepatitis in Long-Evans rats: a potential animal model for fulminant hepatitis in man. Acta Pathol. Jpn. 38, 1369–1375.
Togashi, Y., Li, Y., Jong-Hon, K., Takeichi, N., Fujioka, Y., Nagashima, K., et al. (1992) 6-Penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism. Hepatology 15, 82–87.
Jong-Hon, K., Togashi, Y., Kasai, H., Hosokawa, M., and Takeichi, N. (1993) Prevention of spontaneous hepatocellular carcinoma on Long-Evans Cinnamon rats with hereditary hepatitis by the administration of o-penicillamine. Hepatology 18, 614–620.
Walshe, J. M. (1956) Penicillamine: a new oral therapy for Wilson’s disease. Am. J. Med. 2, 487–495.
Parkes, D. (1984) Wilson’s disease. Br. Med. J. 288, 1180–1181.
Lingam, S., Wilson, J., Nazer, H., and Mowat, A. P. (1987) Neurological abnormalities in Wilson’s disease are reversible. Neuropediatrics 18, 11–12.
Hanaichi, T., Kidokoro, R., Hayashi, H., and Sakamoto, N. (1984) Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes. Lab. Invest. 51, 592–597.
Lerch, K., Johnson, G. F., Grushoff, P. S., and Sternlieb, I. (1985) Canine hepatic lysosomal copper protein: identification as metallothionein. Arch. Biochem. Biophys. 243, 108–114.
Johnson, G. F., Morell, A. G., Stockert, R. J., and Sternlieb, I. (1981) Hepatic lysosomal copper protein in dogs with an inherited copper toxicosis. Hepatology 1, 243–248.
Klein, D., Lichtmannegger, J., Heinzmann, U., Müller-Höcker, J., Michaelsen, S., and Summer, K. H. (1998) Association of copper to metallothionein in hepatic lysosomes of Long-Evans cinnamon (LEC) rats during the development of hepatitis. Eur. J. Clin. Invest. 28, 302–310.
Klein, D., Bartsch, R., and Summer, K. H. (1990) Quantitation of Cu-containing metallothionein by a Cd-saturation method. Anal. Biochem. 189, 35–39.
Kato, N., Nakamura, M., and Uchiyama, T. (1999) 1H NMR studies of the reactions of copper(I) and copper(II) with Dpenicillamine and glutathione. J. Inorg. Biochem. 75, 117–121.
Klein, D., Michaelsen, S., Sato, S., Luz, A., Stampfl, A., and Summer, K. H. (1987) Binding of copper to metallothionein in tissues of the LEC rat with inherited abnormal copper accumulation. Arch. Toxicol. 71, 340–343.
Goldfischer, S. and Sternlieb, I. (1968) Changes in the distribution of hepatic copper in relation to the progression of Wilson’s disease (hepatolenticular degeneration). Am. J. Pathol. 53, 883–901.
Goldfischer, S., Popper, H., and Sternlieb, I. (1980) The significance of variations in distribution of copper in liver disease. Am. J. Pathol. 99, 715–723.
Lindquist, R. R. (1968) Studies on the pathogenesis of hepatolenticular degeneration. III. The effect of copper on rat liver lysosomes. Am. J. Pathol. 53, 903–927.
Myers, B. M., Prendergast, F. G., Holman, R., Kuntz, S. M., and LaRusso, N. F. (1993) Alterations in hepatocyte lysosomes in experimental hepatic copper overload in rats. Gastroenterology 105, 1814–1823.
Kumaratilake, J. S. and McHowell, J. C. (1989) Lysosomes in the pathogenesis of liver injury in chronic copper poisoned sheep: An ultrastructural and morphometric study. J. Compar. Pathol. 100, 381–390.
Mehra, R. K. and Bremner, I. (1985) Studies on the metabolism of rat liver copper-metallothionein. Biochem. J. 227, 903–908.
Hunziker, P. E. (1991) Metal removal from mammalian metallothioneins. Methods Enzymol. 205, 451–452.
Bremner, I. and Mehra, R. K. (1983) Metallothionein: some aspects of its structure and function with special regard to its involvement in copper and zinc metabolism. Chemica Scripta 21, 117–121.
Presta, A., Green, A. R., Zelazowski, A., and Stillman, M. J. (1995) Copper binding to rabbit liver metallothionein. Formation of a continuum of copper(I)-thiolate stoichiometric species. Eur. J. Biochem. 227, 226–240.
Li, H. and Otvos, J. D. (1996) 111Cd NMR studies of the domain specificity of Ag* and Cu’ binding to metallothionein. Biochemistry 35, 13, 929–13, 936.
Sumi, Y., Kawahara, S., Kikuchi, Y., Sawada, J. I., Suzuki, T., and Suzuki, K. T. (1993) Histochemical and immunohistochemical localization of copper, iron and metallothionein in the liver and kidney of LEC rats. Acta Histochem. Cytochem. 26, 5–9.
Scheinberg, I. H. and Sternlieb, I. (1984) Wilson’s disease, in Major Problems in Internal Medicine ( Smith, L. H., Jr., ed.), W. B. Saunders, Philadelphia.
Sauer, J. M., Waalkes, M. P., Hooser, S. B., Kuester, R. K., McQueen, C. A., and Sipes, I. G. (1997) Suppression of Kupffer cell function prevents cadmium induced hepatocellular necrosis in the male Sprague-Dawley rat. Toxicology 121, 155–164.
Edwards, M. J., Keller, B. J., Kauffman, F. C., and Thurman, R. G. (1993) The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol. Appl. Pharmacol. 119, 275–279.
Gibbs, K. and Walshe, J. M. (1990) Liver copper concentration in Wilson’s disease: effect of treatment with “anti-copper” agents. J. Gastroenterol. Hepatol. 5, 520–524.
Scheinberg, I. H., Sternlieb, I., Schilsky, M., and Stockert, R. J. (1987) Penicillamine may detoxify copper in Wilson’s disease. Lancet 2, 95.
Goering, P. L., Tandon, K., and Klaassen, C. D. (1985) Induction of hepatic metallothionein in mouse liver following administration of chelating agents. Toxicol. Appl. Pharmacol. 80, 467–472.
Heilmaier, H. E., Jiang, J. L., Greim, H., Schramel, P., and Summer, K. H. (1986) D-penicillamine induces rat hepatic metallothionein. Toxicology 42, 23–31.
Vallon, J. J. and Badinand, A. (1968) A polarographic study of the redox and complex-forming reactions of penicillamine, N-acetylpenicillamine and copper (I). Anal. Chim. Acta 42, 445–454.
Joyce, D. A. (1989) n-Penicillamine pharmacokinetics and pharmacodynamics in man. Pharmac. Ther. 42, 405–427.
McQuaid, A. and Mason, J. (1990) A comparison of the effects of penicillamine, trientine, and trithiomolybdate on (355)-labeled metallothionein in vitro; implications for Wilson’s disease therapy. J. Inorg. Biochem. 41, 87–92.
McQuaid, A., Lamand, M., and Mason, J. (1992) The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilsons’s disease and arthritis therapy. J. Lab. Clin. Med. 119, 744–750.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Klein, D., Lichtmannegger, J., Summer, K.H. (2002). Copper-Rich Metallothionein Polymers During the Development of Fulminant Hepatitis in LEC Rats. In: Massaro, E.J. (eds) Handbook of Copper Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-288-3_28
Download citation
DOI: https://doi.org/10.1007/978-1-59259-288-3_28
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-266-7
Online ISBN: 978-1-59259-288-3
eBook Packages: Springer Book Archive